Literature DB >> 25119382

Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells.

Priyanka Sathe1, Rebecca B Delconte1, Fernando Souza-Fonseca-Guimaraes2, Cyril Seillet3, Michael Chopin3, Cassandra J Vandenberg3, Lucille C Rankin3, Lisa A Mielke3, Ingela Vikstrom3, Tatiana B Kolesnik3, Sandra E Nicholson3, Eric Vivier4, Mark J Smyth2, Stephen L Nutt3, Stefan P Glaser3, Andreas Strasser3, Gabrielle T Belz3, Sebastian Carotta3, Nicholas D Huntington3.   

Abstract

The cytokine IL-15 is required for natural killer (NK) cell homeostasis; however, the intrinsic mechanism governing this requirement remains unexplored. Here we identify the absolute requirement for myeloid cell leukaemia sequence-1 (Mcl1) in the sustained survival of NK cells in vivo. Mcl1 is highly expressed in NK cells and regulated by IL-15 in a dose-dependent manner via STAT5 phosphorylation and subsequent binding to the 3'-UTR of Mcl1. Specific deletion of Mcl1 in NK cells results in the absolute loss of NK cells from all tissues owing to a failure to antagonize pro-apoptotic proteins in the outer mitochondrial membrane. This NK lymphopenia results in mice succumbing to multiorgan melanoma metastases, being permissive to allogeneic transplantation and being resistant to toxic shock following polymicrobial sepsis challenge. These results clearly demonstrate a non-redundant pathway linking IL-15 to Mcl1 in the maintenance of NK cells and innate immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119382     DOI: 10.1038/ncomms5539

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  72 in total

Review 1.  Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.

Authors:  Peter J Chockley; Venkateshwar G Keshamouni
Journal:  J Immunol       Date:  2016-08-01       Impact factor: 5.422

2.  Stage-specific requirement of kinase PDK1 for NK cells development and activation.

Authors:  Junming He; Yuande Wang; Tian Liu; Guangao Liu; Shasha Chen; Qiaozhen Li; Yuhe Quan; Haoyan Yang; Jin Feng; Song Wang; Meixiang Yang; Zhongjun Dong
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

3.  NK cells require IL-28R for optimal in vivo activity.

Authors:  Fernando Souza-Fonseca-Guimaraes; Arabella Young; Deepak Mittal; Ludovic Martinet; Claudia Bruedigam; Kazuyoshi Takeda; Christopher E Andoniou; Mariapia A Degli-Esposti; Geoffrey R Hill; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-21       Impact factor: 11.205

Review 4.  Bone specific immunity and its impact on metastasis.

Authors:  Nikola Baschuk; Jay Rautela; Belinda S Parker
Journal:  Bonekey Rep       Date:  2015-04-15

Review 5.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

6.  Peripheral natural killer cell maturation depends on the transcription factor Aiolos.

Authors:  Melissa L Holmes; Nicholas D Huntington; Rebecca P L Thong; Jason Brady; Yoshihiro Hayakawa; Christopher E Andoniou; Peter Fleming; Wei Shi; Gordon K Smyth; Mariapia A Degli-Esposti; Gabrielle T Belz; Axel Kallies; Sebastian Carotta; Mark J Smyth; Stephen L Nutt
Journal:  EMBO J       Date:  2014-10-15       Impact factor: 11.598

7.  Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo.

Authors:  Emma M Carrington; Yifan Zhan; Jamie L Brady; Jian-Guo Zhang; Robyn M Sutherland; Natasha S Anstee; Robyn L Schenk; Ingela B Vikstrom; Rebecca B Delconte; David Segal; Nicholas D Huntington; Philippe Bouillet; David M Tarlinton; David Cs Huang; Andreas Strasser; Suzanne Cory; Marco J Herold; Andrew M Lew
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

8.  GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.

Authors:  Mark D Bunting; Antiopi Varelias; Fernando Souza-Fonseca-Guimaraes; Iona S Schuster; Katie E Lineburg; Rachel D Kuns; Peter Fleming; Kelly R Locke; Nicholas D Huntington; Bruce R Blazar; Steven W Lane; Siok-Keen Tey; Kelli P A MacDonald; Mark J Smyth; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Blood       Date:  2016-12-07       Impact factor: 22.113

9.  Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis.

Authors:  Eva M Putz; Camille Guillerey; Kevin Kos; Kimberley Stannard; Kim Miles; Rebecca B Delconte; Kazuyoshi Takeda; Sandra E Nicholson; Nicholas D Huntington; Mark J Smyth
Journal:  Oncoimmunology       Date:  2017-02-07       Impact factor: 8.110

10.  Gab3 is required for IL-2- and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy.

Authors:  Anna Sliz; Kathryn C S Locker; Kristin Lampe; Alzbeta Godarova; David R Plas; Edith M Janssen; Helen Jones; Andrew B Herr; Kasper Hoebe
Journal:  Sci Immunol       Date:  2019-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.